(5Z)-5-[(1,3-benzodioxo-5-yl)methylene]-3-methyl-2-[2-(4-methoxybenzylamino)ethylamino]-3,5-dihydro-4H-imidazol-4-one

ID: ALA1081220

Chembl Id: CHEMBL1081220

PubChem CID: 135860197

Max Phase: Preclinical

Molecular Formula: C22H24N4O4

Molecular Weight: 408.46

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(CNCCNC2=N/C(=C\c3ccc4c(c3)OCO4)C(=O)N2C)cc1

Standard InChI:  InChI=1S/C22H24N4O4/c1-26-21(27)18(11-16-5-8-19-20(12-16)30-14-29-19)25-22(26)24-10-9-23-13-15-3-6-17(28-2)7-4-15/h3-8,11-12,23H,9-10,13-14H2,1-2H3,(H,24,25)/b18-11-

Standard InChI Key:  GMXFIDMOINTTLP-WQRHYEAKSA-N

Alternative Forms

  1. Parent:

    ALA1081220

    ---

Associated Targets(Human)

CSNK2B Tbio Casein kinase I isoform alpha/subunit beta (18 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK5 Tchem Cyclin-dependent kinase 5/CDK5 activator 1 (3697 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3A Tclin Glycogen synthase kinase-3 (736 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 408.46Molecular Weight (Monoisotopic): 408.1798AlogP: 1.97#Rotatable Bonds: 7
Polar Surface Area: 84.42Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.58CX LogP: 2.07CX LogD: 1.67
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.54Np Likeness Score: -0.54

References

1. Debdab M, Renault S, Lozach O, Meijer L, Paquin L, Carreaux F, Bazureau JP..  (2010)  Synthesis and preliminary biological evaluation of new derivatives of the marine alkaloid leucettamine B as kinase inhibitors.,  45  (2): [PMID:19879673] [10.1016/j.ejmech.2009.10.009]

Source